2007•Zhongguo redai yixueRequires access

Blood screening and amniotic fluid diagnosis of Down Syndrome in pregnant women at second rimester

Lian Luo

Open publisher page 0 citations

Abstract

Objective To analyze the effect of AFP andβ-HCG in serum of the pregnant women at the second trimester on the screening of foetus with Down syndrome.Methods The concentration of AFP andβ-HCG in serum were tested by microparticle enzyme.On the basis of some kinds of influencing factors,the risk assessment was made using analytical software.Down syndrome was finally diagnosed by analysis of chromosome in the cell of amniotic fluid.Results 3617 pregnant women at second trimester of pregnancy were screened and 219 were at high risk of Down syndrome with a positive rate of 6.1% .Test of chromosome in the amni- otic fluid cells of 178 high risk Down syndrome women was performed and chromosomal abnormality was observed in 6 of them and 3 were conformed to be with Down syndrome.Conclusion The analysis of AFP andβ-HCG in serum for diagnosis is safe,effective and simple for diagnosis of foetus with Down syndrome.

About this research paper

What this paper is about

Objective To analyze the effect of AFP andβ-HCG in serum of the pregnant women at the second trimester on the screening of foetus with Down syndrome.Methods The concentration of AFP andβ-HCG in serum were tested by microparticle enzyme.On the basis of some kinds of influencing factors,the risk assessment was made using analytical software.Down syndrome was finally diagnosed by analysis of chromosome in the cell of amniotic fluid.Results 3617 pregnant women at second trimester of pregnancy were screened and 219 were at high risk of Down syndrome with a positive rate of 6.1% .Test of chromosome in the amni- otic fluid cells of 178 high risk Down syndrome women was performed and chromosomal abnormality was observed in 6 of them and 3 were conformed to be with Down syndrome.Conclusion The analysis of AFP andβ-HCG in serum for diagnosis is safe,effective and simple for diagnosis of foetus with Down syndrome.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To analyze the effect of AFP andβ-HCG in serum of the pregnant women at the second trimester on the screening of foetus with Down syndrome.Methods The concentration of AFP andβ-HCG in serum were tested by microparticle enzyme.On the basis of some kinds of influencing factors,the risk assessment was made using analytical software.Down syndrome was finally diagnosed by analysis of chromosome in the cell of amniotic fluid.Results 3617 pregnant women at second trimester of pregnancy were screened and 219 were at high risk of Down syndrome with a positive rate of 6.1% .Test of chromosome in the amni- otic fluid cells of 178 high risk Down syndrome women was performed and chromosomal abnormality was observed in 6 of them and 3 were conformed to be with Down syndrome.Conclusion The analysis of AFP andβ-HCG in serum for diagnosis is safe,effective and simple for diagnosis of foetus with Down syndrome.

Key concepts: Amniotic fluid, Medicine, Down syndrome, Obstetrics, Fetus, Pregnancy, Gynecology, Second trimester

Related papers

Back to paper searchBrowse research topicsOriginal source
Blood screening and amniotic fluid diagnosis of Down Syndrome in pregnant women at second rimester — Research Paper | ScholarLens